Collegium Pharmaceutical (COLL) Total Liabilities (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Total Liabilities of $1.3 billion for Q1 2026, down 4.11% year-over-year from $1.4 billion in Q1 2025, and down 1.15% quarter-over-quarter from $1.4 billion in Q4 2025.
Collegium Pharmaceutical (COLL) Total Liabilities (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Total Liabilities history runs 13 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- In Q1 2026, Total Liabilities fell 4.11% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 4.11% YoY), while the FY2025 annual figure was $1.4 billion, down 5.55% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
- The five-year high for Total Liabilities was $1.4 billion in Q4 2024, with the low at $836.8 million in Q2 2024.
- The 5-year median for Total Liabilities is $1.0 billion (2022), against an average of $1.1 billion.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 127.49% in 2022, then fell 17.4% in 2024.
- Collegium Pharmaceutical's Total Liabilities stood at $979.3 million in 2022, then dropped by 3.21% to $947.9 million in 2023, then surged by 51.36% to $1.4 billion in 2024, then decreased by 5.55% to $1.4 billion in 2025, then decreased by 1.15% to $1.3 billion in 2026.
- Business Quant data shows COLL's Total Liabilities at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Bn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.33 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.40 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.40 Bn |
| Jun 30, 2024 | 836.81 Mn |
| Mar 31, 2024 | 892.08 Mn |
| Dec 31, 2023 | 947.88 Mn |
| Sep 30, 2023 | 998.71 Mn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 979.29 Mn |
| Sep 30, 2022 | 1.00 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 489.15 Mn |
| Sep 30, 2021 | 490.71 Mn |